Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Oct 24 | ELVN Enliven Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 30.003 | 816 | 24.48 k | 0 |
18 Oct 24 | ELVN Enliven Therapeutics | Common Stock | Option exercise | Acquire M | No | Yes | 2.48 | 816 | 2.02 k | 816 |
18 Oct 24 | ELVN Enliven Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 2.48 | 816 | 2.02 k | 266,268 |
6 Jun 24 | IOBT IO Biotech | Stock Option Common Stock | Grant | Acquire A | No | No | 1.25 | 45,642 | 57.05 k | 45,642 |
5 Jun 24 | KURA Kura Oncology | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 21.79 | 26,000 | 566.54 k | 26,000 |
11 Apr 24 | ELVN Enliven Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 25.0739 | 20,000 | 501.48 k | 0 |
11 Apr 24 | ELVN Enliven Therapeutics | Common Stock | Option exercise | Acquire M | No | Yes | 2.48 | 20,000 | 49.60 k | 20,000 |
11 Apr 24 | ELVN Enliven Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 2.48 | 20,000 | 49.60 k | 267,084 |
13 Feb 24 | ELVN Enliven Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.85 | 185,000 | 2.75 mm | 185,000 |